OR WAIT null SECS
July 12, 2017
Pfizer’s new format of ibuprofen (AdvilR Liqui-GelsR Minis) uses Catalent’s softgel technology to deliver the formulation in a more concentrated fill, resulting in smaller capsules.
June 05, 2017
Cambrex announces expansions of its North Carolina API pilot plant and Kalskoga, Sweden large-scale manufacturing facility.
May 11, 2017
The company invested approximately $26 million to update its sterile pharmaceutical and development service suites.
January 09, 2017
Catalent announces a development agreement with JOT to evaluate softgel options for a resveratrol drug candidate.
November 28, 2016
Catalent adds two softgel facilities and packaging capabilities with acquisition of Canada-based Accucaps.
August 01, 2016
Bio/pharmaceutical contract service provides continue to invest in development, facility upgrades, technological advancement, and mergers and acquisitions.
March 10, 2016
Hovione will operate a commercial-scale continuous manufacturing facility in New Jersey as part of an agreement with Vertex Pharmaceuticals.
December 14, 2015
Capsugel adds clinical trial and commercial manufacturing, as well as particle engineering services with two acquisitions.
October 02, 2015
Despite emergence of biologics, small-molecule APIs benefit from industry growth.
September 01, 2013
Industry experts share their views on the outsourcing model and the current and future direction of contract chemical API manufacturing.